Ajanta Pharma (AJANTPHARM) Share Price Falls 2.29%: What the Latest Move Means
- September 1, 2026
- Posted by: Kunal Singla
- Category: News
Ajanta Pharma Share Price was at Rs 3,320.30, down 2.29% on the day, with a market capitalisation of Rs 42,623.52 Cr. The move takes the Ajanta Pharma Share Price below the previous close of Rs 3,398.15 and places the stock firmly in today’s decline list among healthcare names. Univest figures confirm the price action, but they do not point to a specific company trigger. For readers tracking Ajanta Pharma Share Price Today, the move matters because the stock remains a Large Cap name with premium valuation metrics and strong profitability ratios. Univest data shows the price action, while Ajanta Pharma Stock News and Ajanta Pharma Share Price News remain focused on the verified numbers rather than a fresh trigger.
Ajanta Pharma (AJANTPHARM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,320.3 |
| Previous Close | Rs 3,398.15 |
| Today's Move | -Rs 77.85 (-2.29%) |
| Open | Rs 3,408.6 |
| High | Rs 3,408.6 |
| Low | Rs 3,313.6 |
| Market Capitalisation | Rs 42,623.52 crore |
| Market Cap Category | Large Cap |
Ajanta Pharma Share Price opened at Rs 3,408.60, matched the day’s high at Rs 3,408.60, and touched a low of Rs 3,313.60 before last trading at Rs 3,320.30. The stock moved Rs 77.85 lower from the previous close of Rs 3,398.15, which equals a 2.29% decline. That places Ajanta Pharma Share Price in a clear price fall for the latest session, while the current price still sits well above the day’s low. With a market cap of Rs 42,623.52 Cr, the company remains classified as a Large Cap under the category provided. For Ajanta Pharma Share Price Today, the key reading is simple: the stock traded lower through the morning range, and the fall now shifts attention toward Ajanta Pharma Fundamental Analysis and sector comparison.
Ajanta Pharma (AJANTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 42,623.52 crore |
| P/E Ratio | 37.42x |
| P/B Ratio | 8.74x |
| ROE | 25.42% |
| ROCE | 32.67% |
| EPS | Rs 90.82 |
| Book Value Per Share | Rs 388.77 |
| Dividend Yield | 0.82% |
Ajanta Pharma (AJANTPHARM) fundamental metrics show P/E 37.42x, P/B 8.74x, ROE 25.42%, ROCE 32.67%. Taken on their own, these numbers offer context rather than a trading signal.
Ajanta Pharma has a market capitalisation of Rs 42,623.52 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 37.42x, P/B at 8.74x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 25.42% and ROCE of 32.67%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 90.82, book value per share of Rs 388.77, dividend yield of 0.82%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.63x, median ROE of 11.61%, median ROCE of 13.46%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 37.42x |
| Benchmark Median P/E | 31.63x |
| Benchmark Average P/E | 47.13x |
| Benchmark P/E Range | 3.21x to 676.52x |
| Company P/B Ratio | 8.74x |
| Benchmark Median P/B | 2.86x |
| Benchmark Average P/B | 4.25x |
| Company ROE | 25.42% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 32.67% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.35% |
| Company Market Capitalisation | Rs 42,623.52 crore |
| Benchmark Median Market Cap | Rs 814.52 crore |
| Benchmark Average Market Cap | Rs 13,724.94 crore |
Ajanta Pharma (AJANTPHARM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Ajanta Pharma (AJANTPHARM) has a P/E ratio of 37.42x, which is above the benchmark median of 31.63x, a difference of +18.31%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ajanta Pharma (AJANTPHARM) has a ROE of 25.42%, which is above the benchmark median of 11.61%, a difference of +118.95%. Ajanta Pharma (AJANTPHARM) has a ROCE of 32.67%, which is above the benchmark median of 13.46%, a difference of +142.72%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,21,539.16 | 34.89 | 4.88 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,47,576 | 85.12 | 14.1 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,77,251.42 | 81.6 | 19.83 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,11,231.65 | 25.18 | 4.21 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,09,796.85 | 102.34 | 19.84 | 18.31 | 18.2 |
Ajanta Pharma (AJANTPHARM) has a P/E ratio of 37.42x compared with the displayed peer median of 81.6x. The comparison is relative and should not be read as a recommendation. Its ROE of 25.42% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 32.67% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Ajanta Pharma (AJANTPHARM) has a market capitalisation of Rs 42,623.52 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Ajanta Pharma
- Ajanta Pharma Share Price is down 2.29% today, so the latest price action is the immediate point of attention.
- Ajanta Pharma Share Price Today reflects a Large Cap company with a market cap of Rs 42,623.52 Cr.
- Ajanta Pharma Fundamental Analysis shows P/E, P/B, ROE and ROCE that sit above broad industry medians.
- Ajanta Pharma Stock News now centres on price movement rather than any verified company-specific catalyst.
- Ajanta Pharma Share Price remains relevant for investors comparing premium valuation with strong profitability ratios.
About Ajanta Pharma
Ajanta Pharma operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company belongs to the Large Cap category under the market-cap classification provided. Its business context is best understood through its position in a competitive drug market where valuation, earnings quality and return ratios often matter more than short-term moves. For Ajanta Pharma Share Price, the key identity is that of an established pharma business tracked alongside major listed peers on NSE and BSE. Univest data places the company in a segment where profitability and capital efficiency are important markers for stock performance, and where Ajanta Pharma Stock Analysis usually draws on financial ratios as much as daily price movement.
Track Ajanta Pharma Share Price on Univest
Use Ajanta Pharma (AJANTPHARM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Ajanta Pharma Share Price on Univest for live price updates, fundamental ratios, market capitalisation, 52-week levels and market insights. The same page also helps you follow Ajanta Pharma Share Price Today, Ajanta Pharma Stock News and Ajanta Pharma Share Price Update in one place. Univest data keeps the focus on verified numbers, so readers can review company fundamentals, peer positioning and sector context without mixing in unsupported commentary.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Ajanta Pharma Share Price falling today?
Ans. Ajanta Pharma Share Price fell 2.29% to Rs 3,320.30 today. Univest figures confirm the price action, but they do not point to a specific company trigger. The stock opened at Rs 3,408.60 and touched a low of Rs 3,313.60.
What is Ajanta Pharma Share Price today?
Ans. Ajanta Pharma Share Price was Rs 3,320.30 at the latest update. It is lower than the previous close of Rs 3,398.15 and marks a same-day decline of Rs 77.85, keeping attention on the stock’s price action.
How much did Ajanta Pharma Share Price fall?
Ans. Ajanta Pharma Share Price declined by 2.29%, or Rs 77.85, in the latest session. The move came after an open of Rs 3,408.60, with the stock trading between Rs 3,313.60 and Rs 3,408.60 during the day.
What is the market capitalisation of Ajanta Pharma?
Ans. Ajanta Pharma has a market capitalisation of Rs 42,623.52 Cr and is classified as a Large Cap. That size context helps place Ajanta Pharma Share Price alongside other listed healthcare companies and peer valuations.
What does Ajanta Pharma fundamental analysis show?
Ans. Ajanta Pharma Fundamental Analysis shows a P/E ratio of 37.42, P/B of 8.74, ROE of 25.42%, ROCE of 32.67%, EPS of Rs 90.82, book value of Rs 388.77 and dividend yield of 0.82%.
How does Ajanta Pharma compare with sector benchmarks?
Ans. Ajanta Pharma Share Price sits in a sector where the same-industry median P/E is 31.63 and average P/E is 47.13. Its ROE and ROCE are above the benchmark median and average, while P/B is also higher.
How does Ajanta Pharma compare with peers?
Ans. Ajanta Pharma Share Price has a P/E of 37.42, below Divi’s Laboratories and Torrent Pharmaceuticals, but above Zydus Lifesciences. Its ROE and ROCE are stronger than all peers listed here, while market cap remains far below Sun Pharma.
What is Ajanta Pharma Stock News saying today?
Ans. Ajanta Pharma Stock News today is driven by the price fall and the verified intraday range. No separate company-specific catalyst is established in the available update, so the focus remains on price movement and valuation context.
Should investors track Ajanta Pharma Share Price on Univest?
Ans. Yes. Univest data lets readers track Ajanta Pharma Share Price with live price updates, fundamental ratios, market capitalisation and sector comparison. That makes it easier to follow today’s decline alongside the company’s financial profile.
